Adult growth hormone deficiency in CEE region: Heterogeneity of the patient pathway.

What It Covers

The paper reports a study of Exogenous HGH, sermorelin & older GHRPs (why they're passed over), published as a review.

An advisory board of leading Central and Eastern European (CEE) endocrinologists was assembled to gain insights into the status of AGHD care in the CEE region.

Topics of discussion included the position of adult hypopituitarism/AGHD in health system priorities, availability and affordability of treatments, awareness of AGHD, practice guidelines used in CEE countries and provisions for long-term care of patients.

Who the Included Studies Covered

By PubMed's age tags, the people studied were adults.

Prior to the meeting, the advisors were asked to summarise, using an itemised survey questionnaire, the usual standards of care for patients with AGHD in their country.

At the meeting, the panel of experts discussed the findings and thereby elucidated similarities and differences among CEE countries; these were compared with international guideline-recommended practices for AGHD.

What Was Measured

The subject headings attached to it are Critical Pathways, Dwarfism, Pituitary, Human Growth Hormone, Hypopituitarism, Practice Guidelines as Topic and Standard of Care.

The authors tagged it with the keywords Adult growth hormone deficiency (AGHD), CEE adult endocrinology advisory board, Central and Eastern Europe (CEE), Growth hormone replacement therapy (GHRT) and Recombinant human growth hormone (rhGH).

What This Means in Plain Language

This is a review of Exogenous HGH, sermorelin & older GHRPs (why they're passed over).

Results are reported in around 6 sentences of the abstract; we leave them to the paper itself rather than summarise them.

The publication is from 2020 (Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society), a journal based in Scotland.

More context: the Exogenous HGH, sermorelin & older GHRPs (why they're passed over) compound page, all human trials.